Citigroup assumed coverage on shares of Healthequity (NASDAQ:HQY) in a research note issued to investors on Thursday, January 4th, The Fly reports. The brokerage issued a buy rating on the stock.

A number of other equities research analysts have also commented on the company. Zacks Investment Research raised Healthequity from a hold rating to a buy rating and set a $58.00 price target for the company in a research report on Wednesday, October 11th. BidaskClub raised Healthequity from a sell rating to a hold rating in a research report on Friday, December 22nd. Chardan Capital increased their price target on Healthequity from $58.00 to $62.00 and gave the company a buy rating in a research report on Wednesday, December 6th. Finally, Cantor Fitzgerald reissued a buy rating and issued a $56.00 price target on shares of Healthequity in a research report on Tuesday, December 5th. Three analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. The company has a consensus rating of Buy and a consensus price target of $58.00.

Shares of Healthequity (HQY) traded down $0.51 during trading hours on Thursday, hitting $51.32. The stock had a trading volume of 41,987 shares, compared to its average volume of 404,993. Healthequity has a one year low of $37.62 and a one year high of $55.31. The firm has a market capitalization of $3,045.76, a price-to-earnings ratio of 70.04, a price-to-earnings-growth ratio of 2.08 and a beta of 1.74.

Healthequity (NASDAQ:HQY) last issued its earnings results on Tuesday, December 5th. The company reported $0.17 earnings per share for the quarter, topping analysts’ consensus estimates of $0.13 by $0.04. Healthequity had a return on equity of 14.47% and a net margin of 21.08%. The company had revenue of $56.80 million for the quarter, compared to analyst estimates of $55.27 million. During the same period in the prior year, the firm earned $0.10 earnings per share. Healthequity’s revenue for the quarter was up 31.0% on a year-over-year basis. sell-side analysts anticipate that Healthequity will post 0.71 EPS for the current fiscal year.

In other Healthequity news, Director Frank Medici sold 419,504 shares of the firm’s stock in a transaction dated Monday, November 6th. The stock was sold at an average price of $52.97, for a total value of $22,221,126.88. Following the completion of the transaction, the director now owns 6,381 shares in the company, valued at approximately $338,001.57. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, VP Ashley Dreier sold 10,000 shares of the firm’s stock in a transaction dated Monday, December 4th. The stock was sold at an average price of $50.97, for a total value of $509,700.00. Following the completion of the transaction, the vice president now owns 15,652 shares of the company’s stock, valued at approximately $797,782.44. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 1,148,534 shares of company stock valued at $59,974,859. Insiders own 19.00% of the company’s stock.

Several institutional investors and hedge funds have recently modified their holdings of HQY. Exane Derivatives raised its holdings in shares of Healthequity by 78.6% during the 4th quarter. Exane Derivatives now owns 4,682 shares of the company’s stock valued at $218,000 after buying an additional 2,060 shares in the last quarter. Robeco Institutional Asset Management B.V. purchased a new position in shares of Healthequity during the 4th quarter valued at about $1,026,000. Jennison Associates LLC purchased a new position in shares of Healthequity during the 4th quarter valued at about $6,545,000. Schwab Charles Investment Management Inc. raised its holdings in shares of Healthequity by 6.0% during the 4th quarter. Schwab Charles Investment Management Inc. now owns 239,024 shares of the company’s stock valued at $11,153,000 after buying an additional 13,635 shares in the last quarter. Finally, Louisiana State Employees Retirement System increased its stake in Healthequity by 6.8% in the 4th quarter. Louisiana State Employees Retirement System now owns 22,100 shares of the company’s stock worth $1,031,000 after purchasing an additional 1,400 shares during the period. Hedge funds and other institutional investors own 98.04% of the company’s stock.

WARNING: “Healthequity (NASDAQ:HQY) Receives New Coverage from Analysts at Citigroup” was published by Marea Informative and is owned by of Marea Informative. If you are viewing this piece of content on another site, it was copied illegally and republished in violation of U.S. and international copyright and trademark legislation. The original version of this piece of content can be viewed at https://www.mareainformativa.com/healthequity-hqy-research-coverage-started-at-citigroup-updated-updated-updated/126743/.

About Healthequity

HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.

The Fly

Analyst Recommendations for Healthequity (NASDAQ:HQY)

Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.